Researchers in large malaria vaccine study face cultural challenges

As researchers prepare to undertake the largest trial ever on an experimental malaria vaccine across sub-Saharan Africa, they realize they will have to contend not only with the difficult conditions but also with suspicions among some of the locals. The undertaking, which is sponsored by GlaxoSmithKline and the Bill & Melinda Gates Foundation, will involve more than 16,000 babies from 11 different parts of the region.

View Full Article in:

Globe and Mail (Toronto) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ